Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interviews

Interview: Andy Scaife, SSP Health

SSP Health is one of only a handful of corporately-run primary care chains in the UK. It was founded in 2002 by two GP partners, Dr. Shikha Pitalia and Dr. Sanjay Pitalia, who are married. It has since grown to 45 practices, most of which are located in the North West of England.

Interview: George Tomeski, Helfie AI

Helfie AI is an Australian start-up that is building what its founder, George Tomeski, describes as “a whole new operating system for human health”. This is not simply hyperbole or PR-speak. What Helfie is building is indeed groundbreaking.

2025 saw considered uptick in European healthcare deals, momentum set to continue into 2026 — Elizabeth Todd, Ropes & Gray

2025 has been a year of gradual recovery for healthcare investments in Europe, according to Elizabeth Todd, Partner and Co-Lead, European Private Equity Transactions Practice at the global law firm Ropes & Gray.

Medtech and minimally invasive devices to see strong growth in 2026 — Amit Karna, Keensight Capital

2025 has been a strong year overall for healthcare investments. In this interview, HBI speaks to Amit Karna, Partner at Keensight Capital, a European growth buyout investor.

Interview: Neil Daly, Skin Analytics

Skin Analytics is a UK company that has developed an AI-based software tool to analyse whether patients with skin lesions have cancer. In a conversation with HBI, the company’s CEO, Neil Daly, explained how AI tools need to be able to make accurate clinical decisions autonomously, without human input, in order to provide an efficiency benefit to the healthcare system.

UK care sector draws strong interest from global private equity

2025 was a busy year for the care sector, with lots of M&A deals either happening, planned, or being considered. Activity has risen sharply and the market is currently at a high point. HBI spoke with Amar Shah, Partner, and Vikas Sharma, Director, both in Healthcare and Life Sciences M&A at Deloitte UK, about trends in the UK social care market, including investment flows, valuations, staffing, technology and expectations for 2026.

Growth equity investors are driving recovery in European healthcare M&A 

The private equity sector has faced a difficult environment for dealmaking over the past two and a half years, due to higher interest rates, regulatory uncertainty and global political pressures. This has led to a slowdown in M&A deal activity in healthcare, as well as other sectors. There are now signs of recovery. Europe is attracting more interest from global investors, especially those seeking high-quality assets with strong growth potential.

Circio looking for partners to help bring circular RNA gene therapy technology to market

Circio, a pre-clinical biotech company that is listed on the Oslo stock exchange, has developed a form of RNA technology that, if successful, could make cell and gene therapy much safer, more effective and more economic, and therefore available to a wide population. HBI sat down with Lubor Gaal, the company’s CFO, at Jefferies’ Global Healthcare Conference in London this week, to understand a bit more about the technology and what the company needs to get to market.

How digital tools are transforming rehabilitation — Interview with Philipp Schulte-Noelle, CEO, MEDIAN Group

In a conversation with HBI, the CEO of MEDIAN Group, Philipp Schulte-Noelle, talks about rehabilitation in Germany and Europe, the role of digital and AI in mental health, and investor interest in the sector.

Interview: Andrew Neville, Inflexion

Inflexion is a European mid-market private equity firm that invests in multiple healthcare sub sectors — medical devices, outsourced pharma services, specialty pharma products and animal health. In a conversation with HBI, Andrew Neville, Partner, explained what Inflexion is looking for in the businesses it invests in, and offers case studies of two companies currently in its portfolio.

Find Us